1.
Lindelöf L, Rantapää-Dahlqvist S, Lundtoft C, et al. A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile. Journal of autoimmunity. 2024;143:103166. doi:10.1016/j.jaut.2023.103166.
1.
Lundtoft C, Eriksson D, Bianchi M, et al. Relation between HLA and copy number variation of steroid 21-hydroxylase in a Swedish cohort of patients with autoimmune Addison’s disease. European journal of endocrinology. 2023. doi:10.1093/ejendo/lvad102.
1.
Hiwa R, Ikari K, Ohmura K, et al. Analysis Identified a Genetically Unique Subset within Rheumatoid Arthritis and Distinct Genetic Background of Rheumatoid Factor Levels from Anticyclic Citrullinated Peptide Antibodies. J Rheumatol. 2018;45(4):470-480. doi:10.3899/jrheum.170363.
1.
Terao C, Okada Y, Ikari K, et al. Genetic landscape of interactive effects of alleles on susceptibility to ACPA(+) rheumatoid arthritis and ACPA levels in Japanese population. J Med Genet. 2017;54(12):853-858. doi:10.1136/jmedgenet-2017-104779.
1.
Bauer J, Becker AJ, Elyaman W, et al. Innate and adaptive immunity in human epilepsies. Epilepsia. 2017;58 Suppl 3:57-68. doi:10.1111/epi.13784.
1.
Kuramoto N, Ohmura K, Ikari K, et al. Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis. Sci Rep. 2017;7(1):6911. doi:10.1038/s41598-017-07137-4.
1.
Scally SW, Law S-C, Ting YT, et al. Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis. Ann Rheum Dis. 2017;76(11):1915-1923. doi:10.1136/annrheumdis-2017-211300.
1.
Eriksson D, Dalin F, Eriksson GN, et al. Cytokine Autoantibody Screening in the Swedish Addison Registry Identifies Patients With Undiagnosed APS1. J Clin Endocrinol Metab. 2018;103(1):179-186. doi:10.1210/jc.2017-01957.
1.
Plenge RM, Seielstad M, Padyukov L, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study. N Engl J Med. 2007;357(12):1199-209. doi:10.1056/NEJMoa073491.
1.
Querol L, Clark PL, Bailey MA, et al. Protein array-based profiling of CSF identifies RBPJ as an autoantigen in multiple sclerosis. Neurology. 2013;81(11):956-63. doi:10.1212/WNL.0b013e3182a43b48.